Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Current Leases (2021 - 2025)

Pliant Therapeutics (PLRX) has disclosed Current Leases for 5 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 166.97% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 166.97% year-over-year, with the annual reading at $1.4 million for FY2025, 166.97% up from the prior year.
  • Current Leases for Q4 2025 was $1.4 million at Pliant Therapeutics, up from $1.2 million in the prior quarter.
  • The five-year high for Current Leases was $2.6 million in Q3 2022, with the low at $98000.0 in Q2 2024.
  • Average Current Leases over 5 years is $1.5 million, with a median of $1.4 million recorded in 2025.
  • The sharpest move saw Current Leases crashed 95.61% in 2024, then soared 1150.0% in 2025.
  • Over 5 years, Current Leases stood at $1.9 million in 2021, then skyrocketed by 31.46% to $2.5 million in 2022, then plummeted by 46.36% to $1.3 million in 2023, then tumbled by 58.88% to $542000.0 in 2024, then soared by 166.97% to $1.4 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.4 million, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.